CN Patent

CN112843062A — 一种含盐酸曲普利啶口服溶液及其制备方法

Assigned to Nanjing Gritpharma Co ltd · Expires 2021-05-28 · 5y expired

What this patent protects

本发明属于药物制剂领域，具体涉及一种含有曲普利啶的复方口服溶液制剂。本发明复方盐酸曲普利啶口服溶液剂使用药学上可接受的辅料，准确分剂量，提高用药安全性，加入芳香剂和甜味剂，口感较好，使用刻度滴管准确分剂量，尤其适用于儿童。本发明产品质量可控和稳定性高，工艺简单，易于吸收，疗效确切，更好的满足临床需要。

USPTO Abstract

本发明属于药物制剂领域，具体涉及一种含有曲普利啶的复方口服溶液制剂。本发明复方盐酸曲普利啶口服溶液剂使用药学上可接受的辅料，准确分剂量，提高用药安全性，加入芳香剂和甜味剂，口感较好，使用刻度滴管准确分剂量，尤其适用于儿童。本发明产品质量可控和稳定性高，工艺简单，易于吸收，疗效确切，更好的满足临床需要。

Drugs covered by this patent

Patent Metadata

Patent number: CN112843062A
Jurisdiction: CN
Classification: —
Expires: 2021-05-28
Drug substance claim: No
Drug product claim: No
Assignee: Nanjing Gritpharma Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.